Search research articles
Contact Us
Filters
Showing results (191-200 of 304) with videos related to
Page
of 31
Sort By:
Seminars in Oncology
|
October 22, 2008
North Central Cancer Treatment Group--achievements and perspectives
Axel Grothey, Alex A Adjei, Steve R Alberts, et al.
The Oncologist
|
September 4, 2009
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study
Mark Kozloff, Marianne Ulcickas Yood, Jordan Berlin, et al.
Pharmacoepidemiology and Drug Safety
|
May 17, 2014
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study
Axel Grothey, E Dawn Flick, Allen L Cohn, et al.
The Oncologist
|
April 21, 2018
Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience
Zhaohui Jin, Cristobal T Sanhueza, Benny Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841
Jan Franko, Qian Shi, Charles D Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
Scott Kopetz, George J Chang, Michael J Overman, et al.
Cancer Chemotherapy and Pharmacology
|
September 23, 2024
Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors
Apostolia Maria Tsimberidou, Axel Grothey, Darren Sigal, et al.
The Oncologist
|
February 16, 2018
A Curative-Intent Trimodality Approach for Isolated Abdominal Nodal Metastases in Metastatic Colorectal Cancer: Update of a Single-Institutional Experience
Benny Johnson, Zhaohui Jin, Michael G Haddock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2008
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials
Hendrik-Tobias Arkenau, Dirk Arnold, Jim Cassidy, et al.
Therapeutic Advances in Medical Oncology
|
March 24, 2020
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)
Hao Xie, Jacqueline M Lafky, Bruce W Morlan, et al.
Page
of 31
Search research articles
Search
Showing results (191-200 of 304) with videos related to
Sort By:
Page
of 31
Seminars in Oncology
|
October 22, 2008
North Central Cancer Treatment Group--achievements and perspectives
Axel Grothey, Alex A Adjei, Steve R Alberts, et al.
The Oncologist
|
September 4, 2009
Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study
Mark Kozloff, Marianne Ulcickas Yood, Jordan Berlin, et al.
Pharmacoepidemiology and Drug Safety
|
May 17, 2014
Bevacizumab exposure beyond first disease progression in patients with metastatic colorectal cancer: analyses of the ARIES observational cohort study
Axel Grothey, E Dawn Flick, Allen L Cohn, et al.
The Oncologist
|
April 21, 2018
Outcome of Mismatch Repair-Deficient Metastatic Colorectal Cancer: The Mayo Clinic Experience
Zhaohui Jin, Cristobal T Sanhueza, Benny Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 14, 2011
Treatment of colorectal peritoneal carcinomatosis with systemic chemotherapy: a pooled analysis of north central cancer treatment group phase III trials N9741 and N9841
Jan Franko, Qian Shi, Charles D Goldman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2009
Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy
Scott Kopetz, George J Chang, Michael J Overman, et al.
Cancer Chemotherapy and Pharmacology
|
September 23, 2024
Phase I-II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor-associated carbohydrate antigen Globo H, in patients with advanced solid tumors
Apostolia Maria Tsimberidou, Axel Grothey, Darren Sigal, et al.
The Oncologist
|
February 16, 2018
A Curative-Intent Trimodality Approach for Isolated Abdominal Nodal Metastases in Metastatic Colorectal Cancer: Update of a Single-Institutional Experience
Benny Johnson, Zhaohui Jin, Michael G Haddock, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 20, 2008
Efficacy of oxaliplatin plus capecitabine or infusional fluorouracil/leucovorin in patients with metastatic colorectal cancer: a pooled analysis of randomized trials
Hendrik-Tobias Arkenau, Dirk Arnold, Jim Cassidy, et al.
Therapeutic Advances in Medical Oncology
|
March 24, 2020
Dual VEGF inhibition with sorafenib and bevacizumab as salvage therapy in metastatic colorectal cancer: results of the phase II North Central Cancer Treatment Group study N054C (Alliance)
Hao Xie, Jacqueline M Lafky, Bruce W Morlan, et al.
Page
of 31